CSA Medical

CSA Medical Develops and Manufactures a Proprietary Interventional Liquid Nitrogen Spray Cryotherapy System, which Utilizes Software-Driven Dosimetry and Specialized Catheters to Deliver Cryospray Within the Airways for Rapid Freezing and Destruction of Damaged Cells, Enabling a Restorative Healing Process. The RejuvenAir System Has Been Approved in the European Union and Is Undergoing Clinical Trials in the United States.